Insmed Inc. buy Royal Bank of Canada
Start price
08.05.26
/
50%
€84.57
Target price
08.05.27
€174.80
Performance (%)
-3.29%
Price
05.06.26
€89.19
Summary
This prediction is currently active. With a performance of -3.29%, the BUY prediction for Insmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 08.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | -2.439% |
| iShares Core DAX® | -1.862% |
| iShares Nasdaq 100 | -3.322% |
| iShares Nikkei 225® | -2.299% |
| iShares S&P 500 | -1.313% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by Royal Bank Of Canada from $220.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat